Feasibility of an Immersive Virtual Reality Intervention for First Trimester D&C: A Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- First Trimester Abortion
- Sponsor
- University of California, Los Angeles
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Number of Participants Able to Use VR Device Throughout the Entire Duration of First Trimester Surgical Abortion.
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Virtual reality (VR) has been used in health care settings to decrease anxiety and pain. This project is a feasibility study to evaluate whether virtual reality can be used in the setting of a first trimester pregnancy termination by D&C and whether the use of virtual reality (VR) headsets can help decrease anxiety for patients during this procedure.
Detailed Description
The investigators will assess the practicality and qualitative experience of women using VR during first trimester surgical abortion under local anesthesia. Semi-structured interviews will be conducted to understand the patient's experience of using VR. Surveys evaluating anxiety will be administered to women before and after surgical abortion. Investigators plan to enroll 30 patients in order to obtain an effect size for future studies. A group of control patients will be enrolled; these patients will receive standard care and will be compared to the anxiety scores of the group receiving VR. The mean and standard deviation of anxiety scores for each group will be used to calculate power for future studies.
Investigators
Aparna Sridhar, MD, MPH, FACOG
Assistant Professor in Obstetrics and Gynecology at David Geffen School of Medicine at UCLA
University of California, Los Angeles
Eligibility Criteria
Inclusion Criteria
- •Age 18 or over
- •Elective surgical abortion under local anesthesia
- •English speaker
Exclusion Criteria
- •No psychiatric history
- •No history of motion sickness or vertigo
- •No history of seizures or epilepsy
- •No recent eye surgery or visual impairment
- •No claustrophobia.
- •No current nausea or vomiting
- •Not on seizure-threshold lowering medications
Outcomes
Primary Outcomes
Number of Participants Able to Use VR Device Throughout the Entire Duration of First Trimester Surgical Abortion.
Time Frame: 15 minutes
Number of participants able to use VR device throughout the entire duration of first trimester surgical abortion.
Secondary Outcomes
- Change in Procedure Related Anxiety as Assessed by the Visual Analog Scale (VAS).(30 min)